Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

To join this study, you must have a clear diagnosis of partial lipodystrophy, whether it's a type you were born with (familial) or one you developed later (acquired).

There are also some reasons you might not be able to join. For example, if you've recently taken part in another medical study where you received an experimental (investigational) medicine, you would likely need to wait a certain amount of time before you could participate in this one. This waiting period is usually at least six months, or longer depending on the specific experimental medicine you used.

The information provided does not detail specific requirements for participation like number of visits, assessments, medication schedule, or total duration. However, generally in such studies, you would expect to have regular visits to the clinic for health checks, blood tests, and to discuss any changes in your health. You would receive the study medication (metreleptin) regularly, likely as an injection under the skin. The doctors and nurses would monitor your health closely, track how you're feeling, and check for any side effects. You would also have follow-up appointments after you finish the main treatment period.